GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Clearbridge Health 1H3.SI · SGD

Health Care · SGX · 🇸🇬 Singapore

Compare

0.00

0.00%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Clearbridge Health

Its shares trade on SGX under the ticker 1H3.SI. It has been listed since 18 December 2017. In the fiscal year to 31 December 2025, it reported revenue of SGD 9.9m and a net loss of SGD 12.9m. At that date it held total assets of SGD 9.8m and shareholders' equity of SGD 3.4m.

Clearbridge Health Ltd. is an invesment holding company, which engages in the provision of laboratory testing services; ownership and operation of medical clinics or centers; and strategic equity participation in precision medical technology companies. The company employs 16 full-time employees The company went IPO on 2017-12-18. The firm is engaged in the provision of laboratory testing services. Its laboratory testing services comprises clinical diagnostics, as well as lifestyle and wellness management testing services. The firm operates through three segments: Strategic investments, Healthcare and information security, and corporate segment. Strategic investments segment involves investments in early-stage biotechnology and information security companies. Healthcare and information security segment involves manufacturing of and research and development on biotechnology products, and provision of information technology consultancy services. The company offers clinical diagnostics through its in-house laboratory, SAM Laboratory Pte.Ltd. The firm's services include health screening and management, cancer diagnosis, biomarker diagnostics, and treatment monitoring and prognosis.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
18 Dec 2017
Employees
16

Leadership

Pay as last reported

  • Mr. Johnson ChenDirector, Founder, since 2021
  • Andrew LordDirector
  • Mr. How Soon MahDirector
  • Mark RyanDirector
  • Mr. Jeremy YeeDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Clearbridge Health Ltd has several key strengths that contribute to its competitive advantage in the market. Firstly, the company has built a strong network of strategic partnerships with leading healthcare providers, enabling it to expand its reach and access a wider customer base. This extensive network allows Clearbridge Health Ltd to offer comprehensive healthcare solutions and deliver quality services to its clients.
  • Another strength of Clearbridge Health Ltd is its focus on cutting-edge technology and innovation. The company leverages advanced medical technologies, such as genetic testing and precision medicine, to deliver personalized healthcare solutions. This technological expertise gives Clearbridge Health Ltd a competitive edge in the industry, attracting customers seeking state-of-the-art healthcare services.
  • Additionally, Clearbridge Health Ltd has a team of highly skilled and experienced professionals. The company's committed and knowledgeable workforce is well-equipped to provide expert medical advice and deliver superior patient care. This expertise enhances the company's reputation and builds trust with customers, positioning Clearbridge Health Ltd as a leading player in the healthcare sector.

Weaknesses

  • Despite its strengths, Clearbridge Health Ltd faces certain weaknesses that could potentially hinder its growth and competitiveness. One weakness is the company's relatively limited geographical presence. Clearbridge Health Ltd predominantly operates within specific regions, which may limit its market share and growth opportunities compared to larger competitors with national or international reach.
  • Another weakness is the potential dependency on external suppliers or partners for certain medical technologies or services. This reliance on external entities can introduce risks of delays, increased costs, or quality control issues. Clearbridge Health Ltd must effectively manage these dependencies to ensure seamless operations and maintain customer satisfaction.

Opportunities

  • Several opportunities exist for Clearbridge Health Ltd to further expand its market presence and enhance its offerings. One opportunity arises from the growing demand for personalized healthcare solutions. As more individuals seek tailored medical treatments and preventive care, Clearbridge Health Ltd can capitalize on this trend by strengthening its expertise in genetic testing, precision medicine, and data analytics to provide highly customized healthcare services.
  • Additionally, Clearbridge Health Ltd can explore strategic partnerships with insurance providers or government agencies to increase accessibility to its services. Collaboration with insurers or government entities can result in broader coverage for patients, potentially driving higher patient volumes and revenue for the company.

Threats

  • Clearbridge Health Ltd faces certain threats that could impact its operations and market position. One significant threat is the intense competition in the healthcare industry. The presence of numerous established players and emerging startups increases the pressure on Clearbridge Health Ltd to continuously innovate and differentiate itself to attract and retain customers. Failure to stay ahead of competitors may result in a loss of market share.
  • Another threat comes from potential changes in healthcare regulations or policies. Shifts in regulatory frameworks can impact the reimbursement rates, licensing requirements, or operational practices, affecting the profitability and viability of Clearbridge Health Ltd's business model. The company must stay informed and adapt accordingly to navigate any regulatory challenges successfully.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.